tradingkey.logo

Inspire Medical Systems Inc

INSP
90.295USD
+4.225+4.91%
Market hours ETQuotes delayed by 15 min
2.62BMarket Cap
58.88P/E TTM

Inspire Medical Systems Inc

90.295
+4.225+4.91%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Inspire Medical Systems Inc

Currency: USD Updated: 2025-11-10

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inspire Medical Systems Inc's Score

Industry at a Glance

Industry Ranking
68 / 209
Overall Ranking
161 / 4611
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 20 analysts
Buy
Current Rating
111.753
Target Price
+36.63%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inspire Medical Systems Inc Highlights

StrengthsRisks
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 96.84% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 57.41, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 32.29M shares, decreasing 18.41% quarter-over-quarter.
Held by Wasatch Global Investors
Star Investor Wasatch Global Investors holds 1.63M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.56.

Financial Health

Currency: USD Updated: 2025-11-10

The company's current financial score is 8.13, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 224.50M, representing a year-over-year increase of 10.49%, while its net profit experienced a year-over-year increase of 46.30%.

Score

Industry at a Glance

Previous score
8.13
Change
0

Financials

9.11

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

5.88

Operational Efficiency

10.00

Growth Potential

8.28

Shareholder Returns

7.38

Inspire Medical Systems Inc's Company Valuation

Currency: USD Updated: 2025-11-10

The company’s current valuation score is 4.60, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 57.41, which is 1699.41% below the recent high of 1033.03 and 926.33% above the recent low of -474.39.

Score

Industry at a Glance

Previous score
4.60
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 68/209
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-10

The company’s current earnings forecast score is 7.20, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Inspire Medical Systems Inc is 105.00, with a high of 171.80 and a low of 80.00.

Score

Industry at a Glance

Previous score
7.20
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 20 analysts
Buy
Current Rating
111.753
Target Price
+29.84%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

110
Total
7
Median
9
Average
Company name
Ratings
Analysts
Inspire Medical Systems Inc
INSP
20
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
32
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
30
1
2
3
...
22

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-10

The company’s current price momentum score is 8.46, which is higher than the Healthcare Equipment & Supplies industry's average of 7.00. Sideways: Currently, the stock price is trading between the resistance level at 93.19 and the support level at 75.20, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.81
Change
1.65

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
2.244
Neutral
RSI(14)
60.035
Neutral
STOCH(KDJ)(9,3,3)
70.289
Buy
ATR(14)
4.302
High Vlolatility
CCI(14)
101.469
Buy
Williams %R
18.733
Overbought
TRIX(12,20)
0.078
Sell
StochRSI(14)
91.920
Overbought
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
83.900
Buy
MA10
79.070
Buy
MA20
79.240
Buy
MA50
79.494
Buy
MA100
96.697
Sell
MA200
128.746
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-10

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 111.12%, representing a quarter-over-quarter decrease of 7.38%. The largest institutional shareholder is The Vanguard, holding a total of 2.99M shares, representing 10.30% of shares outstanding, with 6.12% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
3.49M
-3.00%
The Vanguard Group, Inc.
Star Investors
3.20M
-0.69%
Dragoneer Investment Group, LLC
2.35M
+81.44%
Fidelity Management & Research Company LLC
1.90M
-6.10%
Wasatch Global Investors Inc
Star Investors
1.63M
+7.24%
Baillie Gifford & Co.
Star Investors
1.11M
-3.95%
State Street Investment Management (US)
1.03M
+2.27%
William Blair Investment Management, LLC
769.17K
+11.00%
Frontier Capital Management Company, LLC
693.20K
+59.91%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-10

The company’s current risk assessment score is 3.75, which is lower than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.73. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.75
Change
0
Beta vs S&P 500 index
0.71
VaR
+5.25%
240-Day Maximum Drawdown
+66.54%
240-Day Volatility
+67.81%

Return

Best Daily Return
60 days
+15.33%
120 days
+15.33%
5 years
+28.14%
Worst Daily Return
60 days
-9.43%
120 days
-32.35%
5 years
-33.47%
Sharpe Ratio
60 days
+0.39
120 days
-1.33
5 years
-0.01

Risk Assessment

Maximum Drawdown
240 days
+66.54%
3 years
+77.89%
5 years
+77.89%
Return-to-Drawdown Ratio
240 days
-0.82
3 years
-0.28
5 years
-0.15
Skewness
240 days
-2.55
3 years
-1.52
5 years
-1.10

Volatility

Realised Volatility
240 days
+67.81%
5 years
+59.20%
Standardised True Range
240 days
+7.77%
5 years
+10.84%
Downside Risk-Adjusted Return
120 days
-132.10%
240 days
-132.10%
Maximum Daily Upside Volatility
60 days
+49.03%
Maximum Daily Downside Volatility
60 days
+40.17%

Liquidity

Average Turnover Rate
60 days
+3.17%
120 days
+2.42%
5 years
--
Turnover Deviation
20 days
+155.60%
60 days
+46.73%
120 days
+12.25%

Peer Comparison

Healthcare Equipment & Supplies
Inspire Medical Systems Inc
Inspire Medical Systems Inc
INSP
7.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI